Viewing Study NCT07192068


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2026-01-22 @ 11:13 AM
Study NCT ID: NCT07192068
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2025-06-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.
Sponsor: UNICANCER
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer View
None Sarcoma View
None Head &Amp; Neck Cancer View
None Colorectal Carcinoma View
None Endometrial View
Keywords:

Keywords

Keyword Brief Keyword Text View
None zanidatamab View
None HER2 mutant View
None HER2-IHC3+ View